Category: Finance
-
European Autism Research Consortium Launched
An international coalition of pharmaceutical companies, universities, and advocacy organizations aims to discover new drugs to battle autism spectrum disorder, a collection of conditions affecting social interaction and communication. The project known as European Autism Interventions: A Multicentre Study for Developing New Medications (EU-AIMS) is considered the largest single grant for autism research in the…
-
Osteoporosis Drug Developer Secures $28M in Series B Round
Tarsa Therapeutics Inc., a Philadelphia-based developer of drugs to treat osteoporosis, has completed $28 million in new series B financing, the second round of funding after initial start-up. The financing package, announced on Friday, is led by a new investor in the company, Foresite Capital. The funding is expected to support the next commercialization and…
-
Pennsylvania Awards Five University Commercialization Grants
Pennsylvania’s Department of Community and Economic Development approved $3.15 million for five grants to support research and development in nanotechnology and advanced materials. The grants were made through the Ben Franklin Technology Development Authority’s University Research Commercialization Program that aims to build stronger synergies between university-based research and technology transfer. The Ben Franklin Technology Partners…
-
Merck to Fund New Translational Research Institute
The pharmaceutical company Merck in Whitehouse Station, New Jersey unveiled plans today to establish the California Institute for Biomedical Research (Calibr), an independent, not-for-profit organization to speed the translation of basic biomedical research into new medicines to treat disease. Merck is expected to provide up to $90 million financing for Calibr over seven years. Researchers…
-
Irish Govt to Fund U.S. Life Sciences VC Presence in Ireland
The government of Ireland plans to invest $37.5 million in Sofinnova Ventures, a venture capital firm in Menlo Park, California that supports start-ups in the health care field, for the company to establish a presence in Ireland. Ireland’s Minister for Jobs, Enterprise and Innovation, Richard Bruton (pictured right) made the announcement today during a visit…
-
Texas Instruments Opens New Analog Chip Research Lab
Semiconductor manufacturer Texas Instruments launches today a new Silicon Valley research laboratory in Santa Clara, California. The company says the lab will also provide opportunities for collaboration with researchers and students at universities in the region. The company’s 70-acre Silicon Valley Labs plans to focus on R&D involving analog and mixed analog/digital signal circuits. Projects…
-
Biotech Secures $13M in Series B Funding for Clinical Trial
HemaQuest Pharmaceuticals Inc., a biotechnology company in San Diego, closed a $13 million extension of its series B financing, the second round of funding after initial start-up. The extension is funded by existing investors Aberdare Ventures, De Novo Ventures, Forward Ventures, Latterell Venture Partners, and Lilly Ventures. HemaQuest develops small molecule therapies to treat disorders…
-
Computer Processor Power Scheme Cuts Waste, Energy Use
Engineers and computer scientists at Case Western Reserve University in Cleveland have developed a method for allocating power in computer processors that cuts device energy use by as much as 40 percent. The team led by computer science professor Swarup Bhunia presented their findings in January at the 25th International Conference on VLSI (Very-Large-Scale Integration)…
-
Challenge-Funded Research Studies Animal Testing Alternative
Research at University of Southampton in the U.K. will study in-vitro alternatives for testing the toxicity of drug candidates on animals. The U.K.’s National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) awarded £500,000 ($US 800,400) for the study from its 2011 CRACK IT challenge seeking alternatives to tests with lab…
-
Bellicum Pharma Lands $20M in Series B Finance Round
Bellicum Pharmaceuticals Inc. in Houston, Texas says today it has raised $20 million in series B financing, the second round of investment after initial start-up. The company develops vaccines designed to attack specific disease-producing cells, including those causing life-threatening disorders such as cancer. The privately-held Bellicum says current and new investors contributed to this investment…